BPA for tavneos
Ended Awarded Last action
- Contract number
- 36E79723A0002
- Awardee
-
Chemocentryx, Inc. UEI EVYLGAKQEUL8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $12,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award Blanket Purchase Agreement to Chemocentryx, Inc. for an estimated $12,000,000. The BPA is for TAVNEOS and has a period of performance through August 2023.
TAVNEOS is a prescription medication used to treat adult patients with anti-neutrophil cytoplasmic autoantibody associated vasculitis. As the funding agency, the VA National Acquisition Center leveraged this BPA to establish firm pricing and terms for procuring TAVNEOS to treat eligible veterans through the VA healthcare system. By establishing this single-award BPA, the VA aims to streamline the acquisition process for this specialty medication while taking advantage of pre-negotiated pricing over the 15-month ordering period.
The award was made without any set-asides to Chemocentryx, Inc., which does business as Chemocentryx. As the prime contractor, Chemocentryx will provide TAVNEOS to VA medical centers and other associated facilities nationwide through task orders issued against the BPA. This allows individual VA locations to fulfill patient needs for this treatment as they arise through August 2023 using the pre-competed terms and pricing established in this agreement.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79723A0002?
36E79723A0002 was awarded to Chemocentryx, Inc. by National Acquisition Center (Headquarters) on October 13, 2022.
How much is contract 36E79723A0002 worth?
36E79723A0002's own ceiling is $12,000,000.
Who can order from contract 36E79723A0002?
36E79723A0002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79723A0002 under another contract?
Yes. 36E79723A0002 is a blanket purchase agreement under 36F79722D0192, a federal supply schedule.
Was contract 36E79723A0002 competed?
The extent of competition for 36E79723A0002 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV